Savita Balasaheb Waghmare

Savita Balasaheb Waghmare

Active Director Designated Partner DIN 07693171
DIN 07693171 First appointment Jan 2017 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2017
Shareholding value β€’β€’β€’β€’ Premium profile

About Savita Balasaheb Waghmare

Data last updated:

Savita Balasaheb Waghmare is a Designated Partner at Vitaziya Pharmaceuticals Llp (since 2017). The company operates in Pharma.

DIN 07693171
Primary Designation Designated Partner
Industry Pharma
First Appointment 19 Jan 2017
Oldest Company Age 9 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner19 Jan 20172017Active

Board colleagues of Savita Balasaheb Waghmare

NameDINCompanyDesignation
Sachin Pandurang Bankar07845544Vitaziya Pharmaceuticals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Vitaziya Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Savita Balasaheb Waghmare

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Savita Balasaheb Waghmare

Savita Balasaheb Waghmare currently holds 1 directorship: Vitaziya Pharmaceuticals Llp (Designated Partner, since 19 Jan 2017).

Savita Balasaheb Waghmare was first appointed on 19 Jan 2017 as Designated Partner at Vitaziya Pharmaceuticals Llp.

The current boards of Savita Balasaheb Waghmare's companies include Sachin Pandurang Bankar (Vitaziya Pharmaceuticals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available